Published: 09/4/2026 | Author: Courtney Myers

Surviving an opioid overdose may take you from death’s door but it isn’t the same as getting out of the danger zone. People who reach an ER after an overdose face an 8.6% risk of dying within the following year. Even worse, the opioid addiction med that can improve those odds reaches almost none of them.

Psychiatrist Mark Gold compiled that data. Gold traced what happened next to victims after naloxone brought them back from the brink.

The Year After an Overdose is Dangerous

The good news is overdose deaths tumbled 41% from their peak in 2023. However, 70,000 people still succumb to drugs each year.

Follow-up care rarely gets there in time. One Medicare group of 136,762 individuals who survived a non-fatal drug overdose showed only 4.1% received meds the following year. About 6% filled a naloxone prescription with much of the gap taking place in the countryside.

Another group of 6,000 people who started buprenorphine after an overdose, a mere 8.8% stayed on for 180 days. Even if you include those who tried multiple times, the figure hit less than 11%.

Prescriptions That Never Become Doses

A CDC study noticed that a quarter of people who receive a buprenorphine prescription never fill them at a pharmacy. That number climbed up to 37% in 2024.

Gold says many patients change their minds or pharmacies lack stock. Personal costs, stigma and simple confusion also made people not want to get their prescriptions filled.

Retention is the Real Bottleneck

Buprenorphine lowers opioid use, but only when taking it. So folks need to stay on their meds as directed.

A study of nearly 10,000 overdoses survivors who started medication assisted care stayed an average of 25 days on methadone and 16 days on buprenorphine-naloxone. Gold says people decline the treatment rather than as a failure of the drugs.

The scale of the problem shows in a large trial as well. The HEALing Communities Study aimed to cut opioid overdose deaths by 40%. The final result was a statistically nonsignificant reduction of 8%.

Understanding Opioids, Naloxone & MOUD

Opioids include prescription medications, legal and otherwise. Overdosing suppresses breathing to the point of stopping.

Naloxone reverses that respiratory suppression within minutes. It wears off after 30 minutes, so emergency care is still needed after a reversal. A second dose is sometimes required with fentanyl.

Medications for opioid use disorder are a separate thing. The FDA has approved methadone, buprenorphine and naltrexone.

Each one has a drawback. Buprenorphine is the easiest to start but people don’t fill it or quit altogether. Methadone tends to hold patients longer but is harder to get. Extended-release naltrexone is often limited to a month of coverage.

Medication Works Better Inside a Program

Prescriptions alone aren’t treatment plans.

Many clinicians combined methadone with structured residential and outpatient programs. Meds keep people alive long enough for a community to help them recover. Care systems pair medication with peer support like Narcotics Anonymous and help with housing and employment.

That plays a part in why people leave. Not because the medication stopped working but because they lacked reliable transportation or housing. Folks may run into other health problems or have stopped seeing the point.

NA a Consistent Presence

Narcotics Anonymous meetings and MOUD don’t compete. Use what helps.

Our browsable NA directory covers all 50 states with specific meeting types.

You can also call 800-934-1582(Sponsored) to explore opioid addiction treatment options with an expert.